Earnings for New PhDs

A project examining the relationship between research funding and economic productivity offers insights into where new graduates work and what they earn.

Written byKaren Zusi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, JERICHOThe UMETRICS (Universities: Measuring the Impacts of Research on Innovation, Competitiveness, and Science) project, based at the University of Michigan, examines the monetary investment in scientific research in the U.S. and its impact on the economy. A team of researchers led by Bruce Weinberg of Ohio State University published a segment of the project’s analysis last week (December 10) in Science. The report tracked the outcomes of research funding by surveying where newly minted PhD graduates found employment and how much they earned on average.

The team combined employment data from business registries and the US Census Bureau with graduation data from eight Midwestern universities. The study covered 3,197 individuals, all students who graduated between 2009 and 2011 and who were employed at a different institution between 2010 and 2012.

The top earners were engineers, who garnered an average income of roughly $65,000, followed closely by mathematicians and computer scientists. Other science fields fell around $50,000 and in the high $40,000s range. Biology trailed behind at $36,000 for its new PhD-holders; the authors speculated that the low salary average is due to the high number of postdoc positions.

Approximately 57 percent of the students in the study stayed in academic research, typically to pursue a postdoctoral fellowship. Nearly 40 percent ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies